Epidemiology and management of infectious complications of contemporary management of chronic leukemias
- PMID: 21303335
- DOI: 10.2174/187152611794407755
Epidemiology and management of infectious complications of contemporary management of chronic leukemias
Abstract
This is a review of the epidemiology and management of infectious complications of contemporary management of chronic leukemias. Patients with chronic leukemias typically are affected by nuisance infections due to the underlying hematologic condition, particularly hypogammaglobulinemia in CLL patients. With active treatment, particularly those agents that cause defects in cell-mediated immunity, the incidence of opportunistic infections increases although endogenous bacterial, mycobacterial, and fungal infections also occur. Exogenous treatment with immunoglobulin and antimicrobial prophylaxis, particularly anti-Pneumocystis prophylaxis, may be indicated in select patients. Routine vaccinations should be maintained in these patients and vaccination early in the course of treatment may result in improve protection.
Similar articles
-
Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment.Leuk Lymphoma. 1994 Apr;13(3-4):203-14. doi: 10.3109/10428199409056283. Leuk Lymphoma. 1994. PMID: 8049645 Review.
-
Infectious complications of chronic lymphocytic leukemia.Semin Oncol. 2006 Apr;33(2):240-9. doi: 10.1053/j.seminoncol.2005.12.013. Semin Oncol. 2006. PMID: 16616071 Review.
-
Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate.Leuk Res. 2011 Sep;35(9):e179-80. doi: 10.1016/j.leukres.2011.06.007. Epub 2011 Jul 28. Leuk Res. 2011. PMID: 21802141 No abstract available.
-
A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia.Expert Rev Hematol. 2018 Jan;11(1):57-70. doi: 10.1080/17474086.2018.1407645. Epub 2017 Nov 27. Expert Rev Hematol. 2018. PMID: 29160119 Review.
-
Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.Best Pract Res Clin Haematol. 2010 Mar;23(1):145-53. doi: 10.1016/j.beha.2009.12.004. Best Pract Res Clin Haematol. 2010. PMID: 20620978 Review.
Cited by
-
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.Biomark Insights. 2016 Apr 21;10(Suppl 3):55-68. doi: 10.4137/BMI.S22430. eCollection 2015. Biomark Insights. 2016. PMID: 27127405 Free PMC article. Review.
-
Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients.Blood Cancer J. 2016 Nov 11;6(11):e499. doi: 10.1038/bcj.2016.105. Blood Cancer J. 2016. PMID: 27834937 Free PMC article.
-
Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.Biomedicines. 2022 Aug 19;10(8):2020. doi: 10.3390/biomedicines10082020. Biomedicines. 2022. PMID: 36009567 Free PMC article.
-
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).Cancer Immunol Immunother. 2017 Jan;66(1):77-89. doi: 10.1007/s00262-016-1921-7. Epub 2016 Oct 28. Cancer Immunol Immunother. 2017. PMID: 27796477 Free PMC article.
-
Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.Front Immunol. 2016 Aug 22;7:317. doi: 10.3389/fimmu.2016.00317. eCollection 2016. Front Immunol. 2016. PMID: 27597852 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical